USPTO serial 79039823
CINTENSIFY
Reviewed by CopyMark Law Group
Reg. 3692644Status 404
- Filing date
- Status date
- Registration date
- Oct 6, 2009
- Examiner
- BROWNE, DAYNA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CINTENSIFY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Wiesbaden, DE
Wiesbaden, DE
Wiesbaden, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Schweltzer Comman
Schweltzer Comman Ladas & Parry LLP26 West 61st StreetAtt: Elliot W Lipins, Michael A. CornmanNew York, NY 10023Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | CHEMICAL PRODUCTS FOR USE IN INDUSTRY AND SCIENCE, IN PARTICULAR SUBSTRATES AND COATING COMPOUNDS USED IN CHEMICAL PROCESS TECHNOLOGY, AND BIOLOGICAL PROCESS TECHNOLOGY, NAMELY, POLYMER COATINGS FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL PREPARATIONS AND MEDICAL DEVICES, SUSTAINED RELEASE COATINGS AND PEPTIDE SUBSTRATES FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL PREPARATIONS AND MEDICAL DEVICES, ENZYME SUBSTRATES AND POLYMER SUBSTRATES FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL PREPARATIONS AND MEDICAL DEVICES; CHEMICAL PRODUCTS FOR USE IN INDUSTRY AND SCIENCE, IN PARTICULAR SUBSTRATES AND COATING COMPOUNDS USED IN CHEMICAL PROCESS TECHNOLOGY AND BIOLOGICAL PROCESS TECHNOLOGY, NAMELY, EDIBLE COATINGS FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL PREPARATIONS AND MEDICAL DEVICES | SECTION 71 - CANCELLED | — |
| 005 | PHARMACEUTICAL AND VETERINARY PRODUCTS, NAMELY, BIOCOMPATIBLE MATERIALS SUITABLE TO CARRY CELLS AND/OR DRUGS FOR ADHERENT GROWTH USED FOR USE WITH CELLS AND TISSUES, IMPLANT MATERIALS COMPRISING LIVING TISSUE, ENZYMES, ANTIBODIES, GROWTH FACTORS OR PHARMACEUTICAL AGENTS, NAMELY, AGENTS FOR DIAGNOSTIC APPLICATIONS AND THERAPEUTIC TREATMENT IN THE FIELD OF CANCER, OPHTHALMOLOGY, HAEMATOLOGY, GENEACOLOGY, ORTHOPEDY, NEUROLOGY, NEUROSURGERY, RHEUMATOLOGY, OTOLARYNGOLOGY, CARDIOLOGY, ALL FOR MEDICAL PURPOSES; SURGICAL IMPLANTS, NAMELY, GRAFTS AND STENTS OF ALL TYPES COMPRISING LIVING TISSUE, ENZYMES, ANTIBODIES, GROWTH FACTORS AND PHARMACEUTICAL AGENTS, NAMELY, AGENTS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES, NAMELY, FOR TISSUE REPLACEMENT, TREATMENT OF ORGANS OR SUPPORT OF ORGAN FUNCTION, DERIVED FROM CELL CULTURES | SECTION 71 - CANCELLED | — |
| 010 | SURGICAL, MEDICAL, DENTAL AND VETERINARY APPARATUS AND INSTRUMENTS, NAMELY, CATHETER, INTRACARDIAC CATHETER; MEDICAL, SURGICAL AND ORTHOPAEDIC IMPLANTS FOR OSTEOSYNTHESIS AND JOINT REPLACEMENT MADE OF ARTIFICIAL MATERIALS, ENDOPROSTHESIS, STENTS OF ALL TYPES, IN PARTICULAR FOR SUPPORT OR EXTENSION OF BLOOD VESSELS; BIOCOMPATIBLY COATED STENTS, STENTS FOR ELUTING PHARMACEUTICAL AGENTS SOLD EMPTY; IMPLANTABLE DEPOTS FOR PHARMACEUTICAL AGENTS MADE OF ARTIFICIAL MATERIALS SOLD EMPTY; BONE OR JOINT PROSTHESIS; ARTIFICIAL HEARTS AND PARTS THEREOF, ARTIFICIAL CARDIAC VALVES; CARDIAC PACEMAKER; POROUS SUBSTRATES IN THE NATURE OF IMPLANT COATINGS FOR CELLS AND TISSUES AS PART OF ARTIFICIAL BONE OR JOINT PROSTHESIS, ARTIFICIAL LIMBS, EYES AND TEETH; ORTHOPAEDIC ARTICLES, NAMELY, ORTHOPAEDIC FIXATION TOOLS USED IN ORTHOPEDIC TRANSPLANT AND IMPLANT SURGERY; SUTURE MATERIAL | SECTION 71 - CANCELLED | — |
| 042 | SCIENTIFIC RESEARCH AND TECHNOLOGICAL CONSULTATION SERVICES AND DESIGN PERTAINING TO THE FIELD OF BIOLOGICAL PROCESS TECHNOLOGY, NAMELY, DEVELOPMENT OF MATERIALS, COATINGS, COATING TECHNOLOGIES AND MARKING TECHNOLOGIES FOR MEDICAL, SURGICAL AND ORTHOPAEDIC IMPLANTS FOR THERAPEUTIC AND DIAGNOSTIC PURPOSES, STENTS ELUTING PHARMACEUTICAL AGENTS, STENTS CONTAINING MARKERS, IMPLANTABLE ACTIVE AGENT DEPOTS; DEVELOPMENT OF SUBSTRATES FOR CELLS OR LIVING TISSUE IN BIOLOGICAL PROCESS TECHNOLOGY; DEVELOPMENT OF SUBSTRATE SYSTEMS, MEMBRANE AND SEPARATING TECHNOLOGY FOR CHEMICAL PROCESS TECHNOLOGY | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CINVENTION AG
- Other trademarks owned by CINVENTION AG
- Other trademarks owned by CINVENTION AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named CINTENSIFY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 1, 2017 | UNDN | UNDELIVERABLE MAIL - NO ACTION TAKEN | — |
| Nov 10, 2017 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Nov 10, 2017 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| May 19, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Apr 6, 2017 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Apr 6, 2017 | INPC | INVALIDATION PROCESSED | — |
| Jan 13, 2017 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 13, 2016 | C71T | CANCELLED SECTION 71 | — |
| Jan 27, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 9, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 9, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 6, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 9, 2009 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 6, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 24, 2009 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 24, 2009 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 21, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 1, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 16, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 15, 2009 | ALIE | ASSIGNED TO LIE | — |
| May 29, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 21, 2009 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| May 20, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 20, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 12, 2009 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| May 11, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 11, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 29, 2009 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 29, 2009 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Apr 29, 2009 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Apr 29, 2009 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Mar 24, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 23, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 23, 2009 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 30, 2008 | CFRC | SUBSEQUENT FINAL MAILED | — |
| Oct 30, 2008 | CFRC | SUBSEQUENT FINAL MAILED | — |
| Oct 29, 2008 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Sep 25, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 25, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 23, 2008 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 5, 2008 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Apr 24, 2008 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Mar 31, 2008 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 29, 2008 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 5, 2008 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 5, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 5, 2008 | ALIE | ASSIGNED TO LIE | — |
| Jan 31, 2008 | PAPER RECEIVED | — | |
| Sep 1, 2007 | RFNP | REFUSAL PROCESSED BY IB | — |
| Aug 10, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 10, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 9, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 8, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 1, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 20, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Jul 19, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |